WEKO3
-
RootNode
アイテム
Single Short Retention Instillation of Pirarubicin Prevents Intravesical Recurrence of Low-risk Non Muscle Invasive Bladder Cancer.
http://hdl.handle.net/10422/00012925
http://hdl.handle.net/10422/00012925c5a6b072-2c6f-459c-ac94-5a4e5f298907
| Item type | 学術雑誌論文 / Journal Article(1) | |||||
|---|---|---|---|---|---|---|
| 公開日 | 2021-03-16 | |||||
| タイトル | ||||||
| タイトル | Single Short Retention Instillation of Pirarubicin Prevents Intravesical Recurrence of Low-risk Non Muscle Invasive Bladder Cancer. | |||||
| 言語 | ||||||
| 言語 | eng | |||||
| キーワード | ||||||
| 言語 | en | |||||
| 主題Scheme | Other | |||||
| 主題 | Immediate postoperative single instillation | |||||
| キーワード | ||||||
| 言語 | en | |||||
| 主題Scheme | Other | |||||
| 主題 | non-muscle-invasive bladder cancer | |||||
| キーワード | ||||||
| 言語 | en | |||||
| 主題Scheme | Other | |||||
| 主題 | pirarubicin. | |||||
| 資源タイプ | ||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
| 資源タイプ | journal article | |||||
| アクセス権 | ||||||
| アクセス権 | metadata only access | |||||
| アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
| 著者 |
KAGEYAMA, Susumu
× KAGEYAMA, Susumu× MAEDA, Koki× KUBOTA, Shigehisa× YOSHIDA, Tetsuya× OSAFUNE, Takashi× ARAI, Yutaka× SOGA, Hiroki× NISHIKAWA, Zenkai× SAKANO, Yuji× TAKIMOTO, Keita× 金, 哲將× CHANO, Tokuhiro× KAWAUCHI, Akihiro |
|||||
| 著者別名 |
影山, 進
× 影山, 進× 前田, 航規× 窪田, 成寿× 吉田, 哲也× 新井, 豊× 西川, 全海× 坂野, 祐司× 瀧本, 啓太× 金, 哲將× 茶野, 徳宏× 河内, 明宏 |
|||||
| 抄録 | ||||||
| 内容記述タイプ | Abstract | |||||
| 内容記述 | Background: This study evaluated the efficacy of a single instillation of pirarubicin with a short retention time for preventing intravesical recurrence of low-risk non-muscle-invasive bladder cancer. |
|||||
| 抄録 | ||||||
| 内容記述タイプ | Abstract | |||||
| 内容記述 | Patients and methods: We analyzed 165 patients with low-risk non-muscle-invasive bladder cancer who underwent transurethral surgery. Single instillation of pirarubicin with 15-min retention time immediate after surgery was performed in 47 (28%) patients. The other patients (118, 72%) were treated without instillation therapy. The primary endpoint was recurrence-free survival. |
|||||
| 抄録 | ||||||
| 内容記述タイプ | Abstract | |||||
| 内容記述 | Results: Median overall follow-up was 50 (range=6-134) months. Recurrence-free survival at 1 and 5 years was 91% and 72%, and 79% and 54% in the group treated with pirarubicin, and that treated with surgery alone, respectively (p=0.031). Cox's hazard analysis revealed lack of instillation and larger tumor size (>10 mm) as significant factors for risk of recurrence. No adverse events regarding intravesical chemotherapy were observed. |
|||||
| 抄録 | ||||||
| 内容記述タイプ | Abstract | |||||
| 内容記述 | Conclusion: Pirarubicin instillation with 15-min retention time can prevent intravesical recurrence of low-risk bladder tumors. |
|||||
| 書誌情報 |
en : In vivo (Athens, Greece) 巻 35, 号 2, p. 1141-1145, 発行日 2021 Mar |
|||||
| 出版者 | ||||||
| 出版者 | Dr. George J. Delinasios | |||||
| 出版者 | ||||||
| 出版者 | HighWire | |||||
| ISSN | ||||||
| 収録物識別子タイプ | ISSN | |||||
| 収録物識別子 | 1791-7549 | |||||
| PMID | ||||||
| 識別子タイプ | PMID | |||||
| 関連識別子 | 33622912 | |||||
| DOI | ||||||
| 識別子タイプ | DOI | |||||
| 関連識別子 | https://doi.org/10.21873/invivo.12360 | |||||
| 関連名称 | 10.21873/invivo.12360 | |||||
| 権利 | ||||||
| 権利情報 | t© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved. | |||||
| フォーマット | ||||||
| 内容記述タイプ | Other | |||||
| 内容記述 | ||||||
| 資源タイプ | ||||||
| 内容記述タイプ | Other | |||||
| 内容記述 | Journal Article | |||||
